Search clinical trials for: NET G3

Total 86770 results

Ricardo Mouzo Mirco

Completed

Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients (SENPARIC)

Chronic Kidney Disease

Spain
Federal University of Paraíba

Completed

Evaluation of a Low Fluoride Dentifrice for Caries Control

Dental Caries

Brazil
Diabetes Foundation, India
National Diabetes Obesity and Cholesterol Foundation

Recruiting

To Identify Anytime Hyperglycaemia in Subjects With Normoglycaemia and Prediabetes

Healthy

India
AdventHealth
Integra LifeSciences Corporation

Withdrawn

BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

Prostate Cancer | Prostatectomy | Incontinence, Urinary | Erectile Dysfunction Following Radical Prostatectomy

United States
Azienda Ospedaliera San Giovanni Battista
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte; Rete...

Unknown

Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients (TOTEM)

Endometrial Cancer

Italy
University Hospital, Bordeaux

Recruiting

Effect of Benralizumab on Airway Remodeling in Asthma (BENRAMOD)

Asthma

France
University Hospital, Bordeaux

Completed

Description of the Ability to Learn How to Handle Inhaler Devices in COPD (INTUITIVE)

Chronic Obstructive Pulmonary Disease (COPD)

France
Glaukos Corporation

Terminated

A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra (GCF-041)

Glaucoma, Open-Angle

Germany
Johannes Gutenberg University Mainz
Ipsen; Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA...

Active, not recruiting

Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)

Cancer

Germany
Genexine, Inc.

Completed

Phase I Study GX-G3 in Healthy Subjects (GX-G3)

Healthy

Korea, Republic of
Tomsk National Research Medical Center of the Russian...
Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of Sciences

Completed

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3 (HE3-G3)

Primary Breast Cancer

Russian Federation
Biotheus Inc.

Recruiting

A Study of PM8002 Injection in Combination With Chemotherapy in Patients With NEN

Neuroendocrine Neoplasm

China
Tomsk National Research Medical Center of the Russian...

Enrolling by invitation

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

Breast Cancer Female

Russian Federation
Ascensia Diabetes Care

Completed

Study of an Investigational Glucose Meter System

Diabetes

United States
Johannes Gutenberg University Mainz
Merck KGaA, Darmstadt, Germany

Completed

Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy (AveNEC)

Cancer

Germany
Federal University of Paraíba

Completed

In Vivo Study of Sucrose and Liquid Oral Pediatric Medicines of Long-term Effect on Dental Biofilm pH (SPMedicines)

Dental Biofilm pH

Brazil
Sunnybrook Health Sciences Centre
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in G3 NEC (NET-001)

Neuroendocrine Carcinoma

Canada
General Practitioners Research Institute
G3 Pharmaceuticals

Enrolling by invitation

G3P-01 in Volunteers With Elevated Galectin-3 (Galaxy)

Healthy Aging | Galectin 3

Netherlands
Tomsk National Research Medical Center of the Russian...

Recruiting

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Primary Breast Cancer

Russian Federation
Qilu Hospital of Shandong University
The Affiliated Hospital of Qingdao University; Shandong Provincial Hospital... and other collaborators

Not yet recruiting

Surufatinib in G3 Neuroendocrine Tumors

Neuroendocrine Tumor Grade 3
University of Primorska
Community Healthcare Center dr. Adolf Drolc Maribor (HCM)

Not yet recruiting

Kinesiological / Dietary Supplement Intervention in Knee Osteoarthritis (KDSKOA)

Osteoarthritis, Knee

Slovenia
Boston Scientific Corporation

Completed

The Jetstream G3™ Calcium Study

Peripheral Arterial Disease

United States
Philips Respironics

Withdrawn

Validation of Sleepware G3 Autoscoring Algorithm

Polysomnography Scoring
Adolfo Fontenla

Recruiting

Renal Denervation in Hypertrophic Cardiomyopathy (SNYPER-PS)

Hypertrophic Cardiomyopathy

Spain
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3

Gastroenteropancreatic Neuroendocrine Tumor G3

China
University of California, San Francisco
Merck Sharp & Dohme LLC

Recruiting

Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors

Neuroendocrine Tumors | High Grade Neuroendocrine Carcinoma, Any Site | Well-Differentiated Neuroendocrine Carcinoma

United States
Novartis Pharmaceuticals

Active, not recruiting

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

Advanced Malignancies That Harbor IDHR132 Mutations

Belgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
Serum Institute of India Pvt. Ltd.
PATH

Completed

A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants

Rotavirus Gastroenteritis

India
Haukeland University Hospital
Ullevaal University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark and other collaborators

Completed

Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)

Neuroendocrine Carcinoma

Norway
Henan Cancer Hospital

Unknown

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Gastrointestinal Neuroendocrine Tumor
AIO-Studien-gGmbH
Novartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH

Completed

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study (EVINEC)

Neuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditions

Germany
University of Miami
Integra LifeSciences Corporation

Recruiting

Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy (HAMMER)

Prostate Cancer | Erectile Dysfunction Following Radical Prostatectomy

United States
Reichert, Inc.

Completed

Comparison of Intraocular Pressure Measurements Between Reichert Tono-Vera Tonometer and Goldmann Tonometry

Glaucoma | Intraocular Pressure

United States
Peking University

Recruiting

Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC

Neuroendocrine Neoplasm

China
Boston Medical Center

Terminated

Fecal Microbiota Transplant for Primary CDI

Clostridium Difficile Infection

United States
Hospital de Clinicas de Porto Alegre

Unknown

Effect Physical Exercise in Morbid Obesity

Morbid Obesity

Brazil
Humanity and Health Research Centre
Beijing 302 Hospital

Completed

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients

Chronic Hepatitis C Infection

China
European Institute of Oncology

Recruiting

Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients (TAPIOCA)

Neuroendocrine Neoplasm

Italy
University Health Network, Toronto

Active, not recruiting

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors

Canada
Universidade Federal do Amazonas

Completed

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer (PRONIC-G)

Gastric Cancer | Nutritional Status | Gastric Adenocarcinoma | Cytokines | Microbiome

Brazil
Nanoker Research S.L.
National Research Council, Spain; Horizon 2020 - European Commission; Experior; ICOA Noroeste SLP

Completed

Non-invasive Solution for Periodontal and Peri-implant Diseases (INPERIO) (INPERIO)

Peri-Implantitis

Spain
Karsten Gavenis

Recruiting

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 (CABONEN)

Neuroendocrine Tumors | Neuroendocrine Carcinoma

Germany, Austria
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma

c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM

Spain, Switzerland, Germany, United States, Netherlands
Glaukos Corporation

Completed

Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery

Primary Open-angle Glaucoma

United States
Walter and Eliza Hall Institute of Medical Research
Melbourne Health; Royal Marsden NHS Foundation Trust

Completed

Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours (G3 RPLN PBC)

Testicular Neoplasms

Australia
National Cancer Institute (NCI)

Active, not recruiting

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Soft Tissue Sarcoma | Leiomyosarcoma | Liposarcoma | Undifferentiated Pleomorphic Sarcoma | Soft Tissue Sarcoma of the Trunk and Extremities | Stage I Soft Tissue Sarcoma AJCC v7 | Stage II Soft Tissue Sarcoma AJCC v7 | Sarcoma G2 | Sarcoma G3

United States, Canada
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)

Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9

China
Ascensia Diabetes Care

Completed

Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting

Diabetes

United States
Hoffmann-La Roche

Completed

Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Injection in Healthy Participants

Healthy Participants

United States
Janssen Research & Development, LLC

Completed

Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants

Healthy

United Kingdom

Search clinical trials for: NET G3

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations